Screener
Lexicon Pharmaceuticals LXRX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's enterprise value?
- Lexicon Pharmaceuticals (LXRX) reported enterprise value of $1.08B in Q2 2026.
- How has Lexicon Pharmaceuticals's enterprise value changed year-over-year?
- Lexicon Pharmaceuticals's enterprise value increased by 272.8% year-over-year, from $290.84M to $1.08B.
- What is the long-term trend for Lexicon Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's enterprise value has grown at a 1.1% compound annual growth rate (CAGR), from $395.16M to $416.82M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Lexicon Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude